20-07-2026 15:44 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Historical Volume
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 394.82
NSE Code AUROPHARMA
Dividend Yield % 0.26
Market Cap 900811.63
P/E 37.30
EPS 41.97
Face Value 1  
Exchange : Period From : To :
DateOpen PriceHigh PriceLow PriceClose PriceVolumeTurnover
17-Jul-2026 1550.00 1550.00 1521.50 1534.05 20611 31596037
16-Jul-2026 1563.95 1564.40 1543.00 1548.10 27408 42605924
15-Jul-2026 1559.70 1564.60 1545.65 1551.15 8869 13790338
14-Jul-2026 1540.55 1571.00 1540.55 1552.80 28142 43976843
13-Jul-2026 1551.75 1583.80 1541.60 1549.65 23155 35995644
10-Jul-2026 1580.85 1581.00 1543.70 1564.65 27881 43499804
09-Jul-2026 1569.65 1602.30 1549.65 1586.50 13259 21072306
08-Jul-2026 1583.10 1611.20 1552.65 1556.90 28497 45348207
07-Jul-2026 1600.00 1600.00 1576.05 1583.00 73815 117227013
06-Jul-2026 1622.80 1630.00 1586.00 1593.90 22384 36101093
03-Jul-2026 1566.15 1636.00 1566.15 1620.10 110493 178698988
02-Jul-2026 1555.95 1565.20 1544.10 1560.05 22788 35467971
01-Jul-2026 1580.00 1588.85 1550.00 1552.80 29364 45915169
Page 1 of 1
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.